These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 30040100

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
    Zhou Y, Wang S, Ying X, Wang Y, Geng P, Deng A, Yu Z.
    Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Hou W, Meng Y, Xu XF, Huang ZX, Liu J, Wang ZY, Lin J, Chen WM.
    Eur J Med Chem; 2019 Dec 01; 183():111726. PubMed ID: 31585275
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer.
    Feng C, Rui M, Shen H, Xin Y, Zhang J, Li J, Yue L, Lai W, Xu X.
    Int J Pharm; 2017 Aug 07; 528(1-2):322-333. PubMed ID: 28606508
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH, Lee JS, Bae JW, Choi JH, Lee Y, Son JY, Park KD.
    Int J Pharm; 2015 Nov 10; 495(1):329-335. PubMed ID: 26325307
    [Abstract] [Full Text] [Related]

  • 33. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y, Liu J, Yu X, Liu X, Cheng Y, Zhou C, Li M, Shi L, Deng Y, Liu H, Wang G, Wang L, Wang Z.
    Acta Biomater; 2021 Nov 10; 135():556-566. PubMed ID: 34496281
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate.
    Sivak L, Subr V, Tomala J, Rihova B, Strohalm J, Etrych T, Kovar M.
    Biomaterials; 2017 Jan 10; 115():65-80. PubMed ID: 27886555
    [Abstract] [Full Text] [Related]

  • 36. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
    Han M, Lv Q, Tang XJ, Hu YL, Xu DH, Li FZ, Liang WQ, Gao JQ.
    J Control Release; 2012 Oct 28; 163(2):136-44. PubMed ID: 22940126
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging.
    Xie X, Chen Y, Chen Z, Feng Y, Wang J, Li T, Li S, Qin X, Wu C, Zheng C, Zhu J, You F, Liu Y, Yang H.
    ACS Appl Mater Interfaces; 2019 Nov 27; 11(47):43865-43878. PubMed ID: 31684723
    [Abstract] [Full Text] [Related]

  • 39. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J, Qu H, Jin L, Zeng W, Qin L, Zhang F, Wei X, Lu W, Zhang C, Liang W.
    J Pharm Sci; 2011 Jun 27; 100(6):2267-77. PubMed ID: 21246559
    [Abstract] [Full Text] [Related]

  • 40. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J, Zhang X, Wang F, Wang X, Yang K, Xu M, To KK, Li Q, Fu L.
    Oncotarget; 2015 Dec 29; 6(42):44643-59. PubMed ID: 26556876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.